Sentio Research

Therapeutic areas

Specialist coverage where access to the right clinicians and a clear view of treatment pathways matter most.

Dermatology

Direct proximity to dermatology specialists who prescribe relevant medicines in routine clinical practice.

  • Prescriber access and engagement
  • Real-world treatment pathways
  • Adoption research for specialist therapies

Neurology

Experience across neurological conditions, specialist prescribing and rare neurological diseases.

  • Specialist clinician research
  • Treatment-pathway assessment
  • Complex referral dynamics

Oncology

Work across oncology markets with complex pathways, specialist centres and high-value therapies.

  • Line-of-therapy dynamics
  • Specialist interviews
  • Target product profile response

Rare disease

Research in small populations, specialist centres and highly concentrated treatment pathways.

  • Difficult-to-recruit clinicians
  • Patient and caregiver insight
  • Concentrated centre-of-excellence pathways

Rheumatology

Research with rheumatology specialists across inflammatory and autoimmune conditions, treatment sequencing and biologic / advanced therapy adoption.

  • Specialist rheumatologist engagement
  • Treatment sequencing and switching
  • Biologic and advanced therapy adoption

Metabolic disease and obesity

Relevant for GLP-1 therapies, obesity treatment, diabetes, peptide therapeutics and related cardiometabolic questions.

  • Obesity and diabetes markets
  • Peptide therapeutics
  • Muscle preservation and sarcopenia
  • Cardiometabolic positioning

We describe capability carefully. Experience varies by programme; we do not overstate coverage beyond what the team can support.

Discuss a research question

Share your contact details and the therapeutic area or decision you need to explore.

Our operating framework is being developed with reference to applicable market-research, data-protection and pharmaceutical industry guidance. Project-specific requirements are agreed before fieldwork begins.